Sustaining progress in the development of lifesaving cancer therapies will require aligning policy with science, advancing value-based care, and strengthening collaboration to ensure technologies ...
HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) has won U.S. Food and Drug Administration approval for RYBREVANT FASPRO, the ...
Expanding service lines in community oncology practices enhances patient experience and strengthens community ties, offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback